Sébastien PELTIER (CEO) and Frédéric PELONG (CFO) are taking part on June 20 and 21 in the 10th edition of the annual conference dedicated to French and European Mid & Small Caps. Organized by Portzamparc, this event is one of the unmissable meetings for business leaders and institutional investors in the Mid & Small Caps segment. On this occasion, they will discuss Valbiotis' strategy and the latest news, namely the positive clinical results of the REVERSE-IT study on TOTUM•63.